{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:19:42Z","timestamp":1790363982786,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":450,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1093\/annonc\/mdy211","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T11:08:01Z","timestamp":1528456081000},"page":"1777-1783","source":"Crossref","is-referenced-by-count":62,"title":["Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial"],"prefix":"10.1016","volume":"29","author":[{"given":"M.","family":"Ignatiadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Liti\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Riethdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Proudhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Aalders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Forstbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vuylsteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tryfonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Janni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Pierga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1093\/annonc\/mdy211_bb0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1093\/annonc\/mdy211_bb0015","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1093\/annonc\/mdy211_bb0020","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdy211_bb0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMc0801440","article-title":"HER2 status and benefit from adjuvant trastuzumab in breast cancer","volume":"358","author":"Paik","year":"2008","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1093\/annonc\/mdy211_bb0030","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1200\/JCO.2009.26.2154","article-title":"HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial","volume":"28","author":"Perez","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdy211_bb0035","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-12-3349","article-title":"HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab","volume":"73","author":"Ithimakin","year":"2013","journal-title":"Cancer Res"},{"issue":"7","key":"10.1093\/annonc\/mdy211_bb0040","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/annonc\/mds020","article-title":"Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study","volume":"23","author":"Georgoulias","year":"2012","journal-title":"Ann Oncol"},{"issue":"4 Suppl","key":"10.1093\/annonc\/mdy211_bb0045","first-page":"GS1","volume":"78","author":"Fehrenbacher","year":"2018","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdy211_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejca.2016.04.024","article-title":"Liquid biopsy-based clinical research in early breast cancer: the EORTC 90091-10093 Treat CTC trial","volume":"63","author":"Ignatiadis","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdy211_bb0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdy211_bb0060","doi-asserted-by":"crossref","first-page":"e15624","DOI":"10.1371\/journal.pone.0015624","article-title":"HER2-positive circulating tumor cells in breast cancer","volume":"6","author":"Ignatiadis","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1093\/annonc\/mdy211_bb0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2 Suppl","key":"10.1093\/annonc\/mdy211_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/0008-5472.SABCS-46","article-title":"Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer","volume":"69","author":"Johnston","year":"2009","journal-title":"Cancer Res"},{"issue":"25","key":"10.1093\/annonc\/mdy211_bb0075","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1073\/pnas.0402993101","article-title":"HER-2 gene amplification can be acquired as breast cancer progresses","volume":"101","author":"Meng","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1093\/annonc\/mdy211_bb0080","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdy211_bb0085","first-page":"1","article-title":"Circulating tumor cells predict survival in early average-to-high risk breast cancer patients","volume":"5","author":"Rack","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1093\/annonc\/mdy211_bb0090","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/bcr3647","article-title":"International study on inter-reader variability for circulating tumor cells in breast cancer","volume":"16","author":"Ignatiadis","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"302","key":"10.1093\/annonc\/mdy211_bb0095","doi-asserted-by":"crossref","first-page":"302ra133","DOI":"10.1126\/scitranslmed.aab0021","article-title":"Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer","volume":"7","author":"Garcia-Murillas","year":"2015","journal-title":"Sci Transl Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419341298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419341298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/29\/8\/1777\/25505171\/mdy211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T08:16:34Z","timestamp":1661415394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419341298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0923753419341298"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdy211","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}